Catalyst Biosciences Inc. (CBIO) NASDAQ

$1.21 -0.02 (-1.63%)

Market Cap: $38.63M

As of 11/30/21 10:40 AM EST. Market open.

(CBIO)

Catalyst Biosciences Inc. (CBIO) NASDAQ

$1.21 -0.02 (-1.63%)

Market Cap: $38.63M

As of 11/30/21 10:40 AM EST. Market open.

Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems. Its protease engineering platform has generated two late-stage clinical programs, including MarzAA, a subcutaneously (SQ) administered next-generation engineered coagulation Factor VIIa (FVIIa) for the treatment of ... read more

Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems. Its protease engineering platform has generated two late-stage clinical programs, including MarzAA, a subcutaneously (SQ) administered next-generation engineered coagulation Factor VIIa (FVIIa) for the treatment of episodic bleeding in subjects with rare bleeding disorders. Its complement pipeline includes a pre-clinical C3-degrader program partnered with Biogen for dry age-related macular degeneration, an improved complement factor I protease for SQ replacement therapy in patients with CFI deficiency and C4b-degraders designed to target disorders of the classical complement pathway as well as other complement programs in development. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Nassim Usman
Full Time Employees
56
URL
Address
611 Gateway Blvd Ste 710, California, South San Francisco, 94080-7029.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Nassim Usman
Full Time Employees
56
CEO Compensation (Base)
$480,800
Address
611 Gateway Blvd Ste 710, California, South San Francisco, 94080-7029.
KEY STATS
Open
$1.21
Previous Close
$1.23
Days Range
$1.23 - $1.30
52 week range
$1.23 - $7.55
Volume
145,897
Avg. Volume (30 days)
943,538
Market Cap
$38.63M
Dividend Yield
0.00%
P/E
-0.45
Shares Outstanding
31,409,707
Open
$1.21
Previous Close
$1.23
Days Range
$1.23 - $1.30
52 week range
$1.23 - $7.55
Volume
145,897
Avg. Volume (30 days)
943,538
Market Cap
$38.63M
Dividend Yield
0.00%
P/E
-0.45
Shares Outstanding
31,409,707

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CATALYST BIOSCIENCES INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
USMAN NASSIM President & CEO Aug 09, 2021 Buy $3.62 867 3,139 18,041 Aug 11, 2021, 09:15 AM
Levy Howard Chief Medical Officer Aug 09, 2021 Buy $3.62 639 2,313 639 Aug 11, 2021, 09:14 AM
Blouse Grant E. Chief Scientific Officer Aug 09, 2021 Buy $3.62 1,163 4,210 2,917 Aug 11, 2021, 09:13 AM
USMAN NASSIM President & CEO Apr 05, 2021 Option Exercise $4.63 5,000 23,150 17,174 Apr 07, 2021, 10:55 AM
USMAN NASSIM President & CEO Feb 09, 2021 Buy $4.81 582 2,799 12,174 Feb 22, 2021, 09:33 PM
Levy Howard Chief Medical Officer Feb 09, 2021 Buy $4.81 1,670 8,033 23,390 Feb 22, 2021, 09:33 PM
USMAN NASSIM President & CEO Aug 10, 2020 Buy $4.81 582 2,799 11,592 Aug 12, 2020, 04:12 PM
Levy Howard Chief Medical Officer Aug 10, 2020 Buy $4.81 1,768 8,504 4,268 Aug 12, 2020, 04:11 PM
Levy Howard Chief Medical Officer Mar 16, 2020 Buy $4.05 2,500 10,131 2,500 Mar 17, 2020, 04:23 PM
USMAN NASSIM President & CEO Mar 13, 2020 Buy $3.91 4,000 15,647 11,010 Mar 13, 2020, 06:56 PM
Richard John P Director Mar 13, 2020 Buy $3.98 2,500 9,950 3,716 Mar 13, 2020, 06:56 PM
Cai Veronica Controller Mar 13, 2020 Buy $4.11 2,000 8,220 7,353 Mar 13, 2020, 06:55 PM
Williams Eddie Director Mar 04, 2020 Buy $5.78 2,000 11,560 10,839 Mar 04, 2020, 12:00 AM
Ling Geoffrey M.D. Director Feb 25, 2020 Buy $6.23 3,000 18,692 3,000 Feb 27, 2020, 04:06 PM
LAWLOR AUGUSTINE Director Feb 25, 2020 Sale $6.10 69,401 423,506 0 Feb 25, 2020, 04:21 PM
USMAN NASSIM President & CEO Feb 10, 2020 Option Exercise $6.23 430 2,679 7,010 Feb 12, 2020, 08:28 PM
Levy Howard Chief Medical Officer Feb 10, 2020 Option Exercise $6.23 1,358 8,460 1,358 Feb 12, 2020, 08:28 PM
Cai Veronica Controller Feb 10, 2020 Option Exercise $6.23 1,678 10,454 5,353 Feb 12, 2020, 08:27 PM
Payne Fletcher Chief Financial Officer Aug 12, 2019 Option Exercise $6.51 1,180 7,682 3,744 Aug 12, 2019, 04:22 PM
USMAN NASSIM President & CEO Aug 12, 2019 Option Exercise $6.51 413 2,689 6,580 Aug 12, 2019, 04:21 PM
Richard John P Director May 24, 2019 Buy $8.03 1,000 8,030 1,216 May 28, 2019, 09:45 AM
USMAN NASSIM President & CEO May 21, 2019 Option Exercise $4.63 4,400 20,372 10,567 May 22, 2019, 02:17 PM
Levy Howard Chief Medical Officer May 21, 2019 Option Exercise $4.63 4,400 20,372 16,094 May 22, 2019, 12:23 PM
Payne Fletcher Chief Financial Officer Feb 11, 2019 Option Exercise $7.04 1,002 7,054 3,731 Feb 13, 2019, 07:19 PM
USMAN NASSIM President & CEO Feb 11, 2019 Option Exercise $7.04 350 2,464 6,167 Feb 13, 2019, 05:01 PM
Levy Howard Chief Medical Officer Feb 11, 2019 Option Exercise $7.04 2,485 17,494 11,867 Feb 13, 2019, 05:00 PM
Levy Howard Chief Medical Officer Jan 31, 2019 Option Exercise $4.63 1,500 6,945 9,382 Feb 04, 2019, 04:53 PM
Payne Fletcher Chief Financial Officer Feb 04, 2019 Option Exercise $4.63 1,503 6,959 3,230 Feb 04, 2019, 04:52 PM
USMAN NASSIM President & CEO Jan 31, 2019 Option Exercise $4.63 5,729 26,525 11,041 Feb 04, 2019, 04:51 PM
Levy Howard Chief Medical Officer Nov 26, 2018 Option Exercise $4.63 149 690 7,709 Nov 27, 2018, 05:01 PM
Levy Howard Chief Medical Officer Nov 16, 2018 Option Exercise $4.63 173 801 7,733 Nov 16, 2018, 05:56 PM
Levy Howard Chief Medical Officer Nov 16, 2018 Sale $11.00 173 1,903 7,560 Nov 16, 2018, 05:56 PM
HILL STEPHEN A Director Sep 06, 2018 Option Exercise $10.07 190 1,913 1,190 Sep 06, 2018, 09:41 PM
Levy Howard Chief Medical Officer May 03, 2018 Option Exercise $4.63 7,560 35,003 7,560 May 04, 2018, 04:58 PM
USMAN NASSIM President & CEO Apr 04, 2018 Option Exercise $4.63 88 407 88 Apr 06, 2018, 05:03 PM
Payne Fletcher Chief Financial Officer Mar 26, 2018 Option Exercise $4.63 59 273 59 Mar 28, 2018, 04:11 PM
Flynn James E 10% Owner Mar 06, 2018 Sale $30.87 38,042 1,174,315 849,763 Mar 21, 2018, 04:12 PM
Flynn James E 10% Owner Mar 08, 2018 Sale $29.15 6,756 196,967 813,147 Mar 21, 2018, 04:12 PM
Flynn James E 10% Owner Mar 07, 2018 Sale $30.00 2,748 82,440 308,526 Mar 21, 2018, 04:12 PM
Flynn James E 10% Owner Mar 07, 2018 Sale $30.00 7,252 217,560 814,013 Mar 21, 2018, 04:12 PM
Flynn James E 10% Owner Mar 06, 2018 Sale $30.87 14,419 445,099 322,076 Mar 21, 2018, 04:12 PM
Flynn James E 10% Owner Mar 08, 2018 Sale $29.15 2,561 74,664 308,198 Mar 21, 2018, 04:12 PM
Flynn James E 10% Owner Mar 08, 2018 Sale $29.15 9,317 271,631 1,121,345 Mar 08, 2018, 05:18 PM
Flynn James E 10% Owner Mar 07, 2018 Sale $30.00 10,000 300,000 1,122,539 Mar 08, 2018, 05:18 PM
Flynn James E 10% Owner Mar 06, 2018 Sale $30.87 52,461 1,619,414 1,171,839 Mar 08, 2018, 05:18 PM
USMAN NASSIM President & CEO Dec 17, 2015 Buy $2.00 4,000 8,000 78,375 Dec 18, 2015, 05:43 PM
Payne Fletcher Chief Financial Officer Dec 17, 2015 Buy $2.00 10,000 20,000 25,032 Dec 18, 2015, 05:42 PM
HILL STEPHEN A Director Dec 17, 2015 Buy $2.03 5,000 10,150 20,711 Dec 18, 2015, 05:42 PM
HILL STEPHEN A Director Aug 28, 2015 Option Exercise $6.72 12,146 81,621 15,711 Aug 31, 2015, 03:55 PM
BARRIS PETER J 10% Owner Dec 05, 2013 Sale $5.13 1,000 5,131 0 Dec 05, 2013, 03:15 PM
SANDELL SCOTT D 10% Owner Dec 05, 2013 Sale $5.13 1,000 5,131 0 Dec 05, 2013, 03:15 PM
BARRETT M JAMES 10% Owner Dec 03, 2013 Option Exercise $3.43 15,000 51,525 15,000 Dec 05, 2013, 03:07 PM
BARRETT M JAMES 10% Owner Dec 05, 2013 Sale $5.13 1,000 5,131 0 Dec 05, 2013, 03:07 PM
BARRETT M JAMES 10% Owner Dec 03, 2013 Sale $5.38 15,000 80,754 0 Dec 05, 2013, 03:07 PM
BARRIS PETER J 10% Owner Nov 21, 2013 Sale $5.16 5,333 27,533 1,000 Nov 22, 2013, 05:10 PM
BARRETT M JAMES 10% Owner Nov 21, 2013 Sale $5.16 5,333 27,533 1,000 Nov 22, 2013, 05:09 PM
SANDELL SCOTT D 10% Owner Nov 21, 2013 Sale $5.16 5,333 27,533 1,000 Nov 22, 2013, 05:08 PM
BARRIS PETER J 10% Owner Jun 03, 2013 Option Exercise $0.08 1,000 75 6,333 Jun 04, 2013, 05:47 PM
SANDELL SCOTT D 10% Owner Jun 03, 2013 Option Exercise $0.08 1,000 75 6,333 Jun 04, 2013, 05:47 PM
BARRETT M JAMES 10% Owner Jun 03, 2013 Option Exercise $0.08 1,000 75 6,333 Jun 04, 2013, 05:46 PM
BROWN JULIA R Director May 10, 2013 Buy $5.09 6,000 30,534 6,000 May 13, 2013, 04:26 PM
HILL STEPHEN A President and CEO Mar 08, 2013 Buy $4.48 10,000 44,796 10,000 Mar 11, 2013, 04:43 PM
HILL STEPHEN A President and CEO Mar 11, 2013 Buy $4.38 10,000 43,781 20,000 Mar 11, 2013, 04:43 PM
HILL STEPHEN A President and CEO Mar 11, 2013 Buy $4.38 10,000 43,781 20,000 Mar 11, 2013, 04:33 PM
HILL STEPHEN A President and CEO Mar 08, 2013 Buy $4.48 10,000 44,796 10,000 Mar 11, 2013, 04:33 PM
BVF PARTNERS L P/IL 10% Owner Nov 16, 2012 Buy $4.00 595,000 2,379,822 2,977,919 Nov 20, 2012, 04:21 PM
BARRIS PETER J 10% Owner Nov 19, 2012 Option Exercise $0.08 3,333 250 5,333 Nov 20, 2012, 03:51 PM
SANDELL SCOTT D 10% Owner Nov 19, 2012 Option Exercise $0.08 3,333 250 5,333 Nov 20, 2012, 03:50 PM
KRAMLICH C RICHARD 10% Owner Nov 19, 2012 Option Exercise $0.08 3,333 250 5,333 Nov 20, 2012, 03:50 PM
BVF PARTNERS L P/IL 10% Owner Nov 16, 2012 Buy $5.11 73,500 375,460 2,646,619 Nov 19, 2012, 05:21 PM
BVF PARTNERS L P/IL 10% Owner Nov 14, 2012 Buy $4.00 1,216,712 4,866,848 2,599,919 Nov 19, 2012, 05:21 PM
BVF PARTNERS L P/IL 10% Owner Nov 08, 2012 Buy $4.01 49,329 197,651 1,827,856 Nov 09, 2012, 04:52 PM
BVF PARTNERS L P/IL 10% Owner Nov 07, 2012 Buy $4.08 23,100 94,276 1,795,927 Nov 09, 2012, 04:52 PM
BVF PARTNERS L P/IL 10% Owner Nov 02, 2012 Buy $4.05 57,600 233,482 1,781,627 Nov 02, 2012, 06:35 PM
BVF PARTNERS L P/IL 10% Owner Nov 01, 2012 Buy $4.05 30,100 121,800 1,745,527 Nov 02, 2012, 06:35 PM
BVF PARTNERS L P/IL 10% Owner Oct 31, 2012 Buy $4.06 52,000 210,896 1,738,827 Nov 02, 2012, 06:35 PM
BURRILL STEVEN Director Jul 31, 2012 Option Exercise $0.08 4,333 325 4,333 Aug 01, 2012, 05:22 PM
Richard John P Director Jun 08, 2012 Buy $4.16 7,500 31,192 7,500 Jun 11, 2012, 04:54 PM
Bencherif Merouane SVP, Preclinical Research May 18, 2012 Option Exercise $2.93 15,938 46,698 15,938 May 22, 2012, 03:10 PM
deBethizy J Donald President and CEO Feb 14, 2012 Option Exercise $5.10 798 4,070 798 Feb 16, 2012, 05:54 PM
Richard John P Director Jul 01, 2011 Option Exercise $9.27 2,500 23,175 7,833 Jul 06, 2011, 09:20 AM
Richard John P Director Jul 01, 2011 Sale $21.02 2,500 52,550 5,333 Jul 06, 2011, 09:20 AM
Musso Alan A SVP, CFO & Treasurer Jun 07, 2011 Option Exercise $5.39 30,875 166,340 33,674 Jun 08, 2011, 06:31 PM
Musso Alan A SVP, CFO & Treasurer Jun 07, 2011 Sale $21.80 30,875 672,973 2,799 Jun 08, 2011, 06:31 PM
BROWN JULIA R Director May 13, 2011 Option Exercise $8.70 9,100 79,170 9,100 May 13, 2011, 07:34 PM
BROWN JULIA R Director May 13, 2011 Sale $23.38 9,100 212,782 0 May 13, 2011, 07:34 PM
BURRILL STEVEN Director May 10, 2011 Option Exercise $9.37 16,948 158,803 16,948 May 13, 2011, 07:52 AM
BURRILL STEVEN Director May 12, 2011 Option Exercise $7.32 33,052 241,972 33,052 May 13, 2011, 07:52 AM
BURRILL STEVEN Director May 10, 2011 Sale $24.04 16,948 407,471 0 May 13, 2011, 07:52 AM
BURRILL STEVEN Director May 12, 2011 Sale $23.88 33,052 789,345 0 May 13, 2011, 07:52 AM
BURRILL STEVEN Director May 10, 2011 Sale $24.13 2,000 48,253 0 May 13, 2011, 07:52 AM
BURRILL STEVEN Director May 10, 2011 Option Exercise $9.37 16,948 158,803 16,948 May 12, 2011, 06:59 PM
BURRILL STEVEN Director May 11, 2011 Option Exercise $7.32 33,052 241,972 33,052 May 12, 2011, 06:59 PM
BURRILL STEVEN Director May 10, 2011 Sale $24.13 2,000 48,253 0 May 12, 2011, 06:59 PM
BURRILL STEVEN Director May 10, 2011 Sale $24.04 16,948 407,471 0 May 12, 2011, 06:59 PM
BURRILL STEVEN Director May 11, 2011 Sale $23.88 33,052 789,345 0 May 12, 2011, 06:59 PM
Richard John P Director Apr 01, 2011 Option Exercise $9.27 2,500 23,175 7,833 Apr 04, 2011, 06:41 PM
Richard John P Director Apr 01, 2011 Sale $26.60 2,500 66,500 5,333 Apr 04, 2011, 06:41 PM
Caldwell William S SVP - Drug Discovery and Dev. Mar 31, 2011 Option Exercise $2.93 2,655 7,779 10,390 Apr 04, 2011, 06:34 PM
Caldwell William S SVP - Drug Discovery and Dev. Mar 31, 2011 Sale $26.37 2,655 70,012 7,735 Apr 04, 2011, 06:34 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 09, 2011 Option Exercise $5.55 1,500 8,325 2,659 Mar 11, 2011, 04:41 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 09, 2011 Sale $30.00 1,500 45,000 1,159 Mar 11, 2011, 04:41 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 07, 2011 Option Exercise $5.55 500 2,775 1,659 Mar 09, 2011, 02:53 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 03, 2011 Option Exercise $5.55 5,030 27,917 6,189 Mar 09, 2011, 02:53 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 03, 2011 Sale $30.00 5,030 150,900 1,159 Mar 09, 2011, 02:53 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 07, 2011 Sale $30.00 500 15,001 1,159 Mar 09, 2011, 02:53 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 02, 2011 Option Exercise $5.55 200 1,110 1,359 Mar 03, 2011, 05:10 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 01, 2011 Option Exercise $5.55 12,703 70,502 13,862 Mar 03, 2011, 05:10 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 01, 2011 Sale $30.16 12,703 383,144 1,159 Mar 03, 2011, 05:10 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Mar 02, 2011 Sale $30.00 200 6,000 1,159 Mar 03, 2011, 05:10 PM
Brennan Jeffrey P SVP - Bus. & Commercial Dev. Mar 01, 2011 Option Exercise $2.93 1,264 3,704 1,264 Mar 03, 2011, 05:04 PM
Brennan Jeffrey P SVP - Bus. & Commercial Dev. Mar 01, 2011 Sale $30.00 1,264 37,920 0 Mar 03, 2011, 05:04 PM
Hicks Karen A VP Human Resources Mar 01, 2011 Option Exercise $8.44 1,243 10,489 1,243 Mar 03, 2011, 05:03 PM
Hicks Karen A VP Human Resources Mar 01, 2011 Sale $30.00 1,243 37,290 0 Mar 03, 2011, 05:03 PM
Caldwell William S SVP - Drug Discovery and Dev. Feb 28, 2011 Option Exercise $5.55 15,481 85,920 23,216 Mar 02, 2011, 06:05 PM
Caldwell William S SVP - Drug Discovery and Dev. Mar 01, 2011 Option Exercise $8.51 11,360 96,674 19,095 Mar 02, 2011, 06:05 PM
Caldwell William S SVP - Drug Discovery and Dev. Mar 01, 2011 Sale $30.00 11,360 340,800 7,735 Mar 02, 2011, 06:05 PM
Caldwell William S SVP - Drug Discovery and Dev. Feb 28, 2011 Sale $28.00 15,481 433,468 7,735 Mar 02, 2011, 06:05 PM
Caldwell William S SVP - Drug Discovery and Dev. Feb 16, 2011 Option Exercise $1.75 16,655 29,146 24,390 Feb 18, 2011, 04:42 PM
Caldwell William S SVP - Drug Discovery and Dev. Feb 16, 2011 Sale $26.52 16,655 441,656 7,735 Feb 18, 2011, 04:42 PM
Richard John P Director Jan 19, 2011 Option Exercise $2.71 5,000 13,550 10,333 Jan 20, 2011, 05:45 PM
Richard John P Director Jan 18, 2011 Option Exercise $2.71 2,500 6,775 7,833 Jan 20, 2011, 05:45 PM
Richard John P Director Jan 18, 2011 Sale $27.38 2,500 68,440 5,333 Jan 20, 2011, 05:45 PM
Richard John P Director Jan 19, 2011 Sale $27.11 5,000 135,542 5,333 Jan 20, 2011, 05:45 PM
Bencherif Merouane SVP, Preclinical Research Jan 18, 2011 Option Exercise $5.55 22,800 126,540 22,800 Jan 20, 2011, 05:40 PM
Bencherif Merouane SVP, Preclinical Research Jan 19, 2011 Option Exercise $2.75 30,203 83,069 30,203 Jan 20, 2011, 05:40 PM
Bencherif Merouane SVP, Preclinical Research Jan 19, 2011 Sale $27.09 30,203 818,257 0 Jan 20, 2011, 05:40 PM
Bencherif Merouane SVP, Preclinical Research Jan 18, 2011 Sale $27.17 22,800 619,476 0 Jan 20, 2011, 05:40 PM
Hicks Karen A VP Human Resources Jan 14, 2011 Option Exercise $2.93 1,719 5,037 1,719 Jan 18, 2011, 06:34 AM
Hicks Karen A VP Human Resources Jan 13, 2011 Option Exercise $2.93 3,369 9,871 3,369 Jan 18, 2011, 06:34 AM
Hicks Karen A VP Human Resources Jan 13, 2011 Sale $27.24 3,369 91,760 0 Jan 18, 2011, 06:34 AM
Hicks Karen A VP Human Resources Jan 14, 2011 Sale $27.50 1,719 47,273 0 Jan 18, 2011, 06:34 AM
Hicks Karen A VP Human Resources Jan 12, 2011 Option Exercise $5.91 11,231 66,420 11,231 Jan 13, 2011, 06:55 PM
Hicks Karen A VP Human Resources Jan 11, 2011 Option Exercise $6.26 13,825 86,479 13,825 Jan 13, 2011, 06:55 PM
Hicks Karen A VP Human Resources Jan 11, 2011 Sale $27.02 13,825 373,571 0 Jan 13, 2011, 06:55 PM
Hicks Karen A VP Human Resources Jan 12, 2011 Sale $27.18 11,231 305,298 0 Jan 13, 2011, 06:55 PM
Musso Alan A SVP, CFO & Treasurer Dec 22, 2010 Option Exercise $5.10 4,881 24,893 7,680 Dec 23, 2010, 10:11 AM
Musso Alan A SVP, CFO & Treasurer Dec 21, 2010 Option Exercise $5.10 15,535 79,228 18,334 Dec 23, 2010, 10:11 AM
Musso Alan A SVP, CFO & Treasurer Dec 21, 2010 Sale $26.61 15,535 413,386 2,799 Dec 23, 2010, 10:11 AM
Musso Alan A SVP, CFO & Treasurer Dec 22, 2010 Sale $26.47 4,881 129,200 2,799 Dec 23, 2010, 10:11 AM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Dec 20, 2010 Option Exercise $1.75 8,882 15,544 10,035 Dec 21, 2010, 01:46 PM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Dec 17, 2010 Option Exercise $1.75 2,100 3,675 3,253 Dec 21, 2010, 01:46 PM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Dec 17, 2010 Sale $26.08 2,100 54,765 1,153 Dec 21, 2010, 01:46 PM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Dec 20, 2010 Sale $26.02 8,882 231,120 1,153 Dec 21, 2010, 01:46 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Dec 16, 2010 Option Exercise $8.51 2,700 22,977 3,859 Dec 20, 2010, 11:48 AM
Hodges Mauri K VP Fin + Corp Sys & Controller Dec 16, 2010 Sale $25.24 2,700 68,142 1,159 Dec 20, 2010, 11:48 AM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Dec 16, 2010 Option Exercise $1.75 200 350 1,353 Dec 20, 2010, 11:47 AM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Dec 16, 2010 Sale $25.15 200 5,030 1,153 Dec 20, 2010, 11:47 AM
Caldwell William S SVP - Drug Discovery and Dev. Dec 13, 2010 Option Exercise $1.75 12,000 21,000 19,735 Dec 14, 2010, 05:24 PM
Caldwell William S SVP - Drug Discovery and Dev. Dec 13, 2010 Sale $23.95 12,000 287,377 7,735 Dec 14, 2010, 05:24 PM
Brennan Jeffrey P SVP - Bus. & Commercial Dev. Dec 13, 2010 Option Exercise $2.93 10,000 29,300 10,000 Dec 14, 2010, 05:23 PM
Brennan Jeffrey P SVP - Bus. & Commercial Dev. Dec 13, 2010 Sale $23.86 10,000 238,553 0 Dec 14, 2010, 05:23 PM
Bencherif Merouane SVP, Preclinical Research Dec 10, 2010 Option Exercise $6.00 32,093 192,535 32,093 Dec 14, 2010, 05:22 PM
Bencherif Merouane SVP, Preclinical Research Dec 10, 2010 Sale $24.05 32,093 771,955 0 Dec 14, 2010, 05:22 PM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Dec 08, 2010 Option Exercise $5.10 11,250 57,375 12,403 Dec 10, 2010, 05:43 PM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Dec 08, 2010 Sale $22.68 11,250 255,150 1,153 Dec 10, 2010, 05:43 PM
SKALETSKY MARK B Director Nov 17, 2010 Option Exercise $7.23 29,500 213,145 40,832 Nov 18, 2010, 05:23 PM
SKALETSKY MARK B Director Nov 16, 2010 Option Exercise $2.71 3,000 8,130 14,332 Nov 18, 2010, 05:23 PM
SKALETSKY MARK B Director Nov 16, 2010 Sale $21.76 3,000 65,295 11,332 Nov 18, 2010, 05:23 PM
SKALETSKY MARK B Director Nov 17, 2010 Sale $22.00 29,500 649,000 11,332 Nov 18, 2010, 05:23 PM
BLIXT CHARLES A Director Nov 17, 2010 Option Exercise $9.27 5,500 50,985 5,500 Nov 18, 2010, 05:14 PM
BLIXT CHARLES A Director Nov 16, 2010 Option Exercise $7.56 9,500 71,790 9,500 Nov 18, 2010, 05:14 PM
BLIXT CHARLES A Director Nov 16, 2010 Sale $21.80 9,500 207,067 0 Nov 18, 2010, 05:14 PM
BLIXT CHARLES A Director Nov 17, 2010 Sale $21.76 5,500 119,666 0 Nov 18, 2010, 05:14 PM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Nov 05, 2010 Option Exercise $1.75 700 1,225 1,853 Nov 09, 2010, 06:43 PM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Nov 05, 2010 Sale $25.02 700 17,512 1,153 Nov 09, 2010, 06:43 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Nov 05, 2010 Option Exercise $8.51 1,400 11,914 2,559 Nov 09, 2010, 06:39 PM
Hodges Mauri K VP Fin + Corp Sys & Controller Nov 05, 2010 Sale $25.01 1,400 35,014 1,159 Nov 09, 2010, 06:39 PM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Nov 04, 2010 Option Exercise $1.75 7,784 13,622 8,937 Nov 05, 2010, 11:27 AM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Nov 03, 2010 Option Exercise $1.75 986 1,726 2,139 Nov 05, 2010, 11:27 AM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Nov 03, 2010 Sale $25.05 986 24,699 1,153 Nov 05, 2010, 11:27 AM
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs Nov 04, 2010 Sale $25.07 7,784 195,139 1,153 Nov 05, 2010, 11:27 AM
Hodges Mauri K VP Fin + Corp Sys & Controller Nov 04, 2010 Option Exercise $8.51 7,800 66,378 8,959 Nov 05, 2010, 11:25 AM
Hodges Mauri K VP Fin + Corp Sys & Controller Nov 03, 2010 Option Exercise $8.51 1,000 8,510 2,159 Nov 05, 2010, 11:25 AM
Hodges Mauri K VP Fin + Corp Sys & Controller Nov 03, 2010 Sale $25.06 1,000 25,055 1,159 Nov 05, 2010, 11:25 AM
Hodges Mauri K VP Fin + Corp Sys & Controller Nov 04, 2010 Sale $25.08 7,800 195,605 1,159 Nov 05, 2010, 11:25 AM
Musso Alan A SVP, CFO & Treasurer Oct 28, 2010 Option Exercise $2.93 1,500 4,395 4,299 Oct 28, 2010, 05:32 PM
Musso Alan A SVP, CFO & Treasurer Oct 26, 2010 Option Exercise $2.93 2,000 5,860 4,799 Oct 28, 2010, 05:32 PM
Musso Alan A SVP, CFO & Treasurer Oct 26, 2010 Sale $24.65 2,000 49,295 2,799 Oct 28, 2010, 05:32 PM
Musso Alan A SVP, CFO & Treasurer Oct 28, 2010 Sale $24.60 1,500 36,900 2,799 Oct 28, 2010, 05:32 PM
Musso Alan A SVP, CFO & Treasurer Oct 25, 2010 Option Exercise $2.93 8,500 24,905 11,299 Oct 26, 2010, 04:44 PM
Musso Alan A SVP, CFO & Treasurer Oct 22, 2010 Option Exercise $2.93 600 1,758 3,399 Oct 26, 2010, 04:44 PM
Musso Alan A SVP, CFO & Treasurer Oct 22, 2010 Sale $24.60 600 14,760 2,799 Oct 26, 2010, 04:44 PM
Musso Alan A SVP, CFO & Treasurer Oct 25, 2010 Sale $24.69 8,500 209,892 2,799 Oct 26, 2010, 04:44 PM
DUNTON ALAN W Director Aug 02, 2010 Option Exercise $5.69 6,000 34,140 6,000 Aug 03, 2010, 08:07 PM
DUNTON ALAN W Director Aug 02, 2010 Sale $22.30 6,000 133,791 0 Aug 03, 2010, 08:07 PM
DUNTON ALAN W Director Jul 23, 2010 Option Exercise $5.69 2,336 13,292 2,336 Jul 27, 2010, 07:01 PM
DUNTON ALAN W Director Jul 26, 2010 Option Exercise $5.69 2,864 16,296 2,864 Jul 27, 2010, 07:01 PM
DUNTON ALAN W Director Jul 26, 2010 Sale $21.12 2,864 60,476 0 Jul 27, 2010, 07:01 PM
DUNTON ALAN W Director Jul 23, 2010 Sale $21.00 2,336 49,063 0 Jul 27, 2010, 07:01 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
USMAN NASSIM President & CEO 08/09/2021 3,139
Levy Howard Chief Medical Officer 08/09/2021 2,313
Blouse Grant E. Chief Scientific Officer 08/09/2021 4,210
USMAN NASSIM President & CEO 04/05/2021 23,150
USMAN NASSIM President & CEO 02/09/2021 2,799
Levy Howard Chief Medical Officer 02/09/2021 8,033
USMAN NASSIM President & CEO 08/10/2020 2,799
Levy Howard Chief Medical Officer 08/10/2020 8,504
Levy Howard Chief Medical Officer 03/16/2020 10,131
USMAN NASSIM President & CEO 03/13/2020 15,647
Richard John P Director 03/13/2020 9,950
Cai Veronica Controller 03/13/2020 8,220
Williams Eddie Director 03/04/2020 11,560
Ling Geoffrey M.D. Director 02/25/2020 18,692
LAWLOR AUGUSTINE Director 02/25/2020 423,506
USMAN NASSIM President & CEO 02/10/2020 2,679
Levy Howard Chief Medical Officer 02/10/2020 8,460
Cai Veronica Controller 02/10/2020 10,454
Payne Fletcher Chief Financial Officer 08/12/2019 7,682
USMAN NASSIM President & CEO 08/12/2019 2,689
Richard John P Director 05/24/2019 8,030
USMAN NASSIM President & CEO 05/21/2019 20,372
Levy Howard Chief Medical Officer 05/21/2019 20,372
Payne Fletcher Chief Financial Officer 02/11/2019 7,054
USMAN NASSIM President & CEO 02/11/2019 2,464
Levy Howard Chief Medical Officer 02/11/2019 17,494
Levy Howard Chief Medical Officer 01/31/2019 6,945
Payne Fletcher Chief Financial Officer 02/04/2019 6,959
USMAN NASSIM President & CEO 01/31/2019 26,525
Levy Howard Chief Medical Officer 11/26/2018 690
Levy Howard Chief Medical Officer 11/16/2018 801
Levy Howard Chief Medical Officer 11/16/2018 1,903
HILL STEPHEN A Director 09/06/2018 1,913
Levy Howard Chief Medical Officer 05/03/2018 35,003
USMAN NASSIM President & CEO 04/04/2018 407
Payne Fletcher Chief Financial Officer 03/26/2018 273
Flynn James E 10% Owner 03/06/2018 1,174,315
Flynn James E 10% Owner 03/08/2018 196,967
Flynn James E 10% Owner 03/07/2018 82,440
Flynn James E 10% Owner 03/07/2018 217,560
Flynn James E 10% Owner 03/06/2018 445,099
Flynn James E 10% Owner 03/08/2018 74,664
Flynn James E 10% Owner 03/08/2018 271,631
Flynn James E 10% Owner 03/07/2018 300,000
Flynn James E 10% Owner 03/06/2018 1,619,414
USMAN NASSIM President & CEO 12/17/2015 8,000
Payne Fletcher Chief Financial Officer 12/17/2015 20,000
HILL STEPHEN A Director 12/17/2015 10,150
HILL STEPHEN A Director 08/28/2015 81,621
BARRIS PETER J 10% Owner 12/05/2013 5,131
SANDELL SCOTT D 10% Owner 12/05/2013 5,131
BARRETT M JAMES 10% Owner 12/03/2013 51,525
BARRETT M JAMES 10% Owner 12/05/2013 5,131
BARRETT M JAMES 10% Owner 12/03/2013 80,754
BARRIS PETER J 10% Owner 11/21/2013 27,533
BARRETT M JAMES 10% Owner 11/21/2013 27,533
SANDELL SCOTT D 10% Owner 11/21/2013 27,533
BARRIS PETER J 10% Owner 06/03/2013 75
SANDELL SCOTT D 10% Owner 06/03/2013 75
BARRETT M JAMES 10% Owner 06/03/2013 75
BROWN JULIA R Director 05/10/2013 30,534
HILL STEPHEN A President and CEO 03/08/2013 44,796
HILL STEPHEN A President and CEO 03/11/2013 43,781
HILL STEPHEN A President and CEO 03/11/2013 43,781
HILL STEPHEN A President and CEO 03/08/2013 44,796
BVF PARTNERS L P/IL 10% Owner 11/16/2012 2,379,822
BARRIS PETER J 10% Owner 11/19/2012 250
SANDELL SCOTT D 10% Owner 11/19/2012 250
KRAMLICH C RICHARD 10% Owner 11/19/2012 250
BVF PARTNERS L P/IL 10% Owner 11/16/2012 375,460
BVF PARTNERS L P/IL 10% Owner 11/14/2012 4,866,848
BVF PARTNERS L P/IL 10% Owner 11/08/2012 197,651
BVF PARTNERS L P/IL 10% Owner 11/07/2012 94,276
BVF PARTNERS L P/IL 10% Owner 11/02/2012 233,482
BVF PARTNERS L P/IL 10% Owner 11/01/2012 121,800
BVF PARTNERS L P/IL 10% Owner 10/31/2012 210,896
BURRILL STEVEN Director 07/31/2012 325
Richard John P Director 06/08/2012 31,192
Bencherif Merouane SVP, Preclinical Research 05/18/2012 46,698
deBethizy J Donald President and CEO 02/14/2012 4,070
Richard John P Director 07/01/2011 23,175
Richard John P Director 07/01/2011 52,550
Musso Alan A SVP, CFO & Treasurer 06/07/2011 166,340
Musso Alan A SVP, CFO & Treasurer 06/07/2011 672,973
BROWN JULIA R Director 05/13/2011 79,170
BROWN JULIA R Director 05/13/2011 212,782
BURRILL STEVEN Director 05/10/2011 158,803
BURRILL STEVEN Director 05/12/2011 241,972
BURRILL STEVEN Director 05/10/2011 407,471
BURRILL STEVEN Director 05/12/2011 789,345
BURRILL STEVEN Director 05/10/2011 48,253
BURRILL STEVEN Director 05/10/2011 158,803
BURRILL STEVEN Director 05/11/2011 241,972
BURRILL STEVEN Director 05/10/2011 48,253
BURRILL STEVEN Director 05/10/2011 407,471
BURRILL STEVEN Director 05/11/2011 789,345
Richard John P Director 04/01/2011 23,175
Richard John P Director 04/01/2011 66,500
Caldwell William S SVP - Drug Discovery and Dev. 03/31/2011 7,779
Caldwell William S SVP - Drug Discovery and Dev. 03/31/2011 70,012
Hodges Mauri K VP Fin + Corp Sys & Controller 03/09/2011 8,325
Hodges Mauri K VP Fin + Corp Sys & Controller 03/09/2011 45,000
Hodges Mauri K VP Fin + Corp Sys & Controller 03/07/2011 2,775
Hodges Mauri K VP Fin + Corp Sys & Controller 03/03/2011 27,917
Hodges Mauri K VP Fin + Corp Sys & Controller 03/03/2011 150,900
Hodges Mauri K VP Fin + Corp Sys & Controller 03/07/2011 15,001
Hodges Mauri K VP Fin + Corp Sys & Controller 03/02/2011 1,110
Hodges Mauri K VP Fin + Corp Sys & Controller 03/01/2011 70,502
Hodges Mauri K VP Fin + Corp Sys & Controller 03/01/2011 383,144
Hodges Mauri K VP Fin + Corp Sys & Controller 03/02/2011 6,000
Brennan Jeffrey P SVP - Bus. & Commercial Dev. 03/01/2011 3,704
Brennan Jeffrey P SVP - Bus. & Commercial Dev. 03/01/2011 37,920
Hicks Karen A VP Human Resources 03/01/2011 10,489
Hicks Karen A VP Human Resources 03/01/2011 37,290
Caldwell William S SVP - Drug Discovery and Dev. 02/28/2011 85,920
Caldwell William S SVP - Drug Discovery and Dev. 03/01/2011 96,674
Caldwell William S SVP - Drug Discovery and Dev. 03/01/2011 340,800
Caldwell William S SVP - Drug Discovery and Dev. 02/28/2011 433,468
Caldwell William S SVP - Drug Discovery and Dev. 02/16/2011 29,146
Caldwell William S SVP - Drug Discovery and Dev. 02/16/2011 441,656
Richard John P Director 01/19/2011 13,550
Richard John P Director 01/18/2011 6,775
Richard John P Director 01/18/2011 68,440
Richard John P Director 01/19/2011 135,542
Bencherif Merouane SVP, Preclinical Research 01/18/2011 126,540
Bencherif Merouane SVP, Preclinical Research 01/19/2011 83,069
Bencherif Merouane SVP, Preclinical Research 01/19/2011 818,257
Bencherif Merouane SVP, Preclinical Research 01/18/2011 619,476
Hicks Karen A VP Human Resources 01/14/2011 5,037
Hicks Karen A VP Human Resources 01/13/2011 9,871
Hicks Karen A VP Human Resources 01/13/2011 91,760
Hicks Karen A VP Human Resources 01/14/2011 47,273
Hicks Karen A VP Human Resources 01/12/2011 66,420
Hicks Karen A VP Human Resources 01/11/2011 86,479
Hicks Karen A VP Human Resources 01/11/2011 373,571
Hicks Karen A VP Human Resources 01/12/2011 305,298
Musso Alan A SVP, CFO & Treasurer 12/22/2010 24,893
Musso Alan A SVP, CFO & Treasurer 12/21/2010 79,228
Musso Alan A SVP, CFO & Treasurer 12/21/2010 413,386
Musso Alan A SVP, CFO & Treasurer 12/22/2010 129,200
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 12/20/2010 15,544
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 12/17/2010 3,675
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 12/17/2010 54,765
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 12/20/2010 231,120
Hodges Mauri K VP Fin + Corp Sys & Controller 12/16/2010 22,977
Hodges Mauri K VP Fin + Corp Sys & Controller 12/16/2010 68,142
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 12/16/2010 350
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 12/16/2010 5,030
Caldwell William S SVP - Drug Discovery and Dev. 12/13/2010 21,000
Caldwell William S SVP - Drug Discovery and Dev. 12/13/2010 287,377
Brennan Jeffrey P SVP - Bus. & Commercial Dev. 12/13/2010 29,300
Brennan Jeffrey P SVP - Bus. & Commercial Dev. 12/13/2010 238,553
Bencherif Merouane SVP, Preclinical Research 12/10/2010 192,535
Bencherif Merouane SVP, Preclinical Research 12/10/2010 771,955
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 12/08/2010 57,375
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 12/08/2010 255,150
SKALETSKY MARK B Director 11/17/2010 213,145
SKALETSKY MARK B Director 11/16/2010 8,130
SKALETSKY MARK B Director 11/16/2010 65,295
SKALETSKY MARK B Director 11/17/2010 649,000
BLIXT CHARLES A Director 11/17/2010 50,985
BLIXT CHARLES A Director 11/16/2010 71,790
BLIXT CHARLES A Director 11/16/2010 207,067
BLIXT CHARLES A Director 11/17/2010 119,666
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 11/05/2010 1,225
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 11/05/2010 17,512
Hodges Mauri K VP Fin + Corp Sys & Controller 11/05/2010 11,914
Hodges Mauri K VP Fin + Corp Sys & Controller 11/05/2010 35,014
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 11/04/2010 13,622
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 11/03/2010 1,726
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 11/03/2010 24,699
Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs 11/04/2010 195,139
Hodges Mauri K VP Fin + Corp Sys & Controller 11/04/2010 66,378
Hodges Mauri K VP Fin + Corp Sys & Controller 11/03/2010 8,510
Hodges Mauri K VP Fin + Corp Sys & Controller 11/03/2010 25,055
Hodges Mauri K VP Fin + Corp Sys & Controller 11/04/2010 195,605
Musso Alan A SVP, CFO & Treasurer 10/28/2010 4,395
Musso Alan A SVP, CFO & Treasurer 10/26/2010 5,860
Musso Alan A SVP, CFO & Treasurer 10/26/2010 49,295
Musso Alan A SVP, CFO & Treasurer 10/28/2010 36,900
Musso Alan A SVP, CFO & Treasurer 10/25/2010 24,905
Musso Alan A SVP, CFO & Treasurer 10/22/2010 1,758
Musso Alan A SVP, CFO & Treasurer 10/22/2010 14,760
Musso Alan A SVP, CFO & Treasurer 10/25/2010 209,892
DUNTON ALAN W Director 08/02/2010 34,140
DUNTON ALAN W Director 08/02/2010 133,791
DUNTON ALAN W Director 07/23/2010 13,292
DUNTON ALAN W Director 07/26/2010 16,296
DUNTON ALAN W Director 07/26/2010 60,476
DUNTON ALAN W Director 07/23/2010 49,063
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
1.70%
1Q
09/30/2021
03/31/2021
7.03%
2Q

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
1.70%
1Q
03/31/2021
7.03%
2Q